Arimidex is now approved to treat EARLY breast cancer

October 2002

Arimidex is now approved to treat EARLY breast cancer.

Tamoxifen is currently the standard for women with estrogen receptor-positive breast cancer.

Both tamoxifen and Arimidex reduce the effect of estrogen on tumor cells...but they work in different ways. Tamoxifen blocks estrogen receptors...Arimidex suppresses estrogen synthesis.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote